Next-generation sequencing analysis of the human T-cell and B-cell receptor repertoire diversity before and after hepatitis B vaccination.
Adult
Complementarity Determining Regions
/ genetics
Genetic Variation
Hepatitis B
/ prevention & control
Hepatitis B Antibodies
/ blood
Hepatitis B Vaccines
/ administration & dosage
High-Throughput Nucleotide Sequencing
Humans
Male
Receptors, Antigen, B-Cell
/ genetics
Receptors, Antigen, T-Cell, alpha-beta
/ genetics
Sequence Analysis, DNA
T-Lymphocytes
/ immunology
Vaccination
Young Adult
B-cell receptor
Hepatitis B vaccine
T-cell receptor
complementary determining region 3
diversity
repertoire
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
2019
2019
Historique:
pubmed:
5
4
2019
medline:
7
5
2020
entrez:
5
4
2019
Statut:
ppublish
Résumé
The hepatitis B (HB) vaccine effectively prevents the incidence of hepatitis B virus (HBV) infection. However, vaccine failure occurs in 5-10% of the recipients. The precise mechanisms leading to responsiveness to the HB vaccine are poorly understood. High-throughput sequencing (HTS) may help clarify the immune response to the HB vaccine, so we applied this method to investigate whether the HB vaccine induced a specific change in the T-cell receptor (TCR) and B-cell receptor (BCR) repertoires. We conducted HTS of the TCR β chain and BCR IgG heavy (H) chain complementary determining region 3 (CDR3) repertoires in five volunteers before and after the second and third immunizations with the HB vaccine. The HB surface antibody (HBsAb) levels were >10 mIU/ml after the third vaccination in all five participants. The TCR β chain CDR3 repertoire diversity significantly increased, while the BCR IgG H chain CDR3 repertoire diversity significantly decreased after the second vaccination. Although there was no marked inter-individual variation in terms of the numbers of unique reads, it is possible that the TCR β chain and BCR IgG H chain CDR3 repertoires may have changed within the same numbers of unique reads. Our data failed to identify the specific dominant clones that responded to the HB vaccine. In summary, the TCR β chain CDR3 repertoire diversity significantly increased, while the BCR IgG H chain CDR3 repertoire diversity significantly decreased, after the second HB vaccination. These diversity changes might be associated with a better response to the HB vaccine.
Identifiants
pubmed: 30945971
doi: 10.1080/21645515.2019.1600987
pmc: PMC6930056
doi:
Substances chimiques
Complementarity Determining Regions
0
Hepatitis B Antibodies
0
Hepatitis B Vaccines
0
Receptors, Antigen, B-Cell
0
Receptors, Antigen, T-Cell, alpha-beta
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2738-2753Références
Curr Opin Immunol. 2005 Oct;17(5):468-75
pubmed: 16098723
Hum Immunol. 1997 Aug-Sep;56(1-2):57-69
pubmed: 9455494
J Microbiol Biotechnol. 2017 Dec 28;27(12):2089-2093
pubmed: 29032640
Vaccine. 2011 Jan 17;29(4):706-11
pubmed: 21111021
Hum Vaccin Immunother. 2013 Jul;9(7):1466-76
pubmed: 23571167
Vaccine. 2002 Aug 19;20(25-26):3193-6
pubmed: 12163271
Vaccine. 2017 Jan 23;35(4):703-710
pubmed: 28043736
PLoS One. 2011;6(8):e22365
pubmed: 21829618
Genome Med. 2013 Oct 30;5(10):98
pubmed: 24172704
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4928-33
pubmed: 24639495
PLoS One. 2017 Nov 9;12(11):e0187661
pubmed: 29121107
N Engl J Med. 2001 Oct 4;345(14):1042-53
pubmed: 11586958
J Viral Hepat. 2018 Apr;25(4):363-372
pubmed: 29193549
Hum Vaccin Immunother. 2013 Aug;9(8):1673-8
pubmed: 23807362
BMC Immunol. 2016 Oct 11;17(1):38
pubmed: 27729009
Antiviral Res. 2010 Jul;87(1):40-9
pubmed: 20412816
J Immunol. 2014 Mar 15;192(6):2689-98
pubmed: 24510963
J Immunol. 2015 Jan 1;194(1):252-261
pubmed: 25392534
Tissue Antigens. 1997 Jul;50(1):8-14
pubmed: 9243749
Int Immunol. 1996 Apr;8(4):525-31
pubmed: 8671639
Front Immunol. 2017 May 03;8:389
pubmed: 28515723
Hepatology. 2004 Apr;39(4):978-88
pubmed: 15057902
Genes Immun. 2016 Apr;17(3):153-64
pubmed: 26963138
Hepatology. 2001 Aug;34(2):372-6
pubmed: 11481622
Environ Health Perspect. 2001 Aug;109(8):757-64
pubmed: 11564609
J Immunol. 2005 Jun 1;174(11):7446-52
pubmed: 15905594
J Med Virol. 2010 May;82(6):929-33
pubmed: 20419805
Pediatr Infect Dis J. 2013 Apr;32(4):307-13
pubmed: 23249904
J Mol Diagn. 2017 Jan;19(1):72-83
pubmed: 27815002
Vaccine. 2012 Aug 24;30(39):5708-13
pubmed: 22824342
Nat Biotechnol. 2013 Feb;31(2):166-9
pubmed: 23334449
Clin Exp Immunol. 2016 Jan;183(1):50-6
pubmed: 26332693
Iran J Allergy Asthma Immunol. 2015 Jun;14(3):233-45
pubmed: 26546891
Int J Immunogenet. 2011 Dec;38(6):463-73
pubmed: 22059555
Vaccine. 2012 Feb 21;30(9):1644-9
pubmed: 22245310
PLoS One. 2017 Jan 23;12(1):e0170479
pubmed: 28114326